5 stories mentioning SHA:688799Updated just now
Every FINWIRES story that references SHA:688799, newest first.
Hunan Warrant Pharmaceutical (SHA:688799) subsidiary Hunan Warrant Pharmaceutical Chiral Drugs received marketing approval from China's National Medical Products Administration for its iguratimod active pharmaceutical ingredient.The ingredient is used to make tablets for active rheumatoid arthritis, according to a Thursday filing with the Shanghai bourse.
Hunan Warrant Pharmaceutical (SHA:688799) received the drug registration certificate from China's National Medical Products Administration for loxoprofen sodium patches, according to a Tuesday filing with the Shanghai bourse.The patches are indicated for osteoarthritis, muscle pain, or trauma-induced swelling or pain.
China's drug regulator granted Hunan Warrant Pharmaceutical (SHA:688799) subsidiary Hunan Warrant Pharmaceutical Chiral marketing approval for its fluorescein sodium chemical raw material.The chemical is used as dye for diagnostic fundus angiography and iris vascular fluorescein angiography for eye exams, according to a Wednesday filing with the Shanghai bourse.
Hunan Warrant Pharmaceutical's (SHA:688799) subsidiary, Hunan Huana Chiral Drugs, secured a good manufacturing practice or GMP certificate for its facilities for two drugs, according to a Shanghai bourse filing on Saturday.The pharmaceutical company's shares slipped 1% at the close of Monday's trade.The Hunan Warrant Pharmaceutical Chiral Drugs found that the facilities producing norepinephrine bitartrate and isoproterenol hydrochloride passed its GMP inspection.
Hunan Warrant Pharmaceutical (SHA:688799) received approval from China's National Medical Products Administration for beraprost sodium tablets, according to a Shanghai bourse filing on Saturday.The pharmaceutical company's shares slipped 1% at the close of Monday's trade.The drug is used to improve symptoms such as ulcers, intermittent claudication, pain, and cold sensation caused by chronic arterial occlusive diseases.
